Isolation and characterization of novel RECK tumor suppressor gene splice variants

Marina Trombetta-Lima1,2, Sheila Maria Brochado Winnischofer3, Marcos Angelo Almeida Demasi1,2

  • 1Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, SP, 05508-000, Brazil.

Oncotarget
|October 3, 2015
PubMed

Insights

Canonical RECK expression and a higher ratio of canonical to alternative transcripts correlate with better glioblastoma multiforme survival. Alternative RECK variants may promote tumor growth, impacting prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis.
  • RECK (Reversion-Inducing Cysteine-Rich Proteinous Knockoff) is known to suppress tumor invasion by inhibiting matrix metalloproteinases (MMPs).
  • Previous studies suggest RECK expression correlates with better outcomes in various cancers.

Purpose of the Study:

  • To investigate novel alternatively spliced variants of the RECK gene (RECK-B and RECK-I).
  • To determine the expression levels and profiles of canonical and alternative RECK transcripts in malignant astrocytomas.
  • To assess the prognostic significance of RECK expression and its variants in GBM patients.

Main Methods:

  • Isolation and sequencing of novel RECK variants (RECK-B, RECK-I) using RT-PCR.
  • Quantification of canonical and alternative RECK transcript expression via qRT-PCR in astrocytoma tissues and normal RNA panels.
  • Analysis of RECK-B overexpression effects on U87MG and T98G cell lines, including anchorage-independent growth and MMP expression.

Main Results:

  • Higher canonical RECK expression correlates with improved overall survival in GBM patients undergoing chemotherapy.
  • An elevated ratio of canonical to alternative RECK transcript expression is associated with better patient prognosis.
  • Overexpression of the RECK-B variant in GBM cells enhanced anchorage-independent growth without affecting MMP-2 or MMP-9 levels.

Conclusions:

  • Novel RECK transcript variants (RECK-B and RECK-I) have been identified.
  • The ratio of canonical to alternative RECK transcript expression may serve as a prognostic biomarker for GBM.
  • RECK transcript variants may play opposing roles in GBM pathogenesis, influencing tumor behavior and patient outcomes.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
26.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K